Concepedia

Gregory Fanning

GF

Statistics

Publications

35

Citations

2.4K

H-Index

26

Active since

1996

Affiliations

Janssen (Belgium)(Current)

Johnson & Johnson (Australia)

UNSW Sydney

Medivir (Sweden)

The Royal Free Hospital

Gregory Fanning is an author at Janssen (Belgium) specializing in life sciences, antiviral therapy, and molecular virology.

Publications per year

1996–2020

35

Publications

35

Genetic markers may predict disease behavior in patients with ulcerative colitis

Maria Roussomoustakaki, Jack Satsangi, Ken I. Welsh et al. · Gastroenterology · 1997 · 277 citations · Full text

, , +16

<i>In Vitro</i> Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435

Oliver Lenz, Thierry Verbinnen, Tse‐I Lin et al. · Antimicrobial Agents and Chemotherapy · 2010 · 211 citations · Full text

, , +17

In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor

Tse‐I Lin, Oliver Lenz, Gregory Fanning et al. · Antimicrobial Agents and Chemotherapy · 2009 · 190 citations · Full text

, , +17

Design and cloning strategies for constructing shRNA expression vectors

Glen McIntyre, Gregory Fanning · BMC Biotechnology · 2006 · 159 citations · Full text

, , +15

Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients

H. W. Reesink, Gregory Fanning, Khalid Abou Farha et al. · Gastroenterology · 2009 · 155 citations · Full text

, , +14

1–5 of 35